pulmicort and Fecal-Incontinence

pulmicort has been researched along with Fecal-Incontinence* in 2 studies

Reviews

1 review(s) available for pulmicort and Fecal-Incontinence

ArticleYear
Microscopic colitis: pathophysiology and clinical management.
    The lancet. Gastroenterology & hepatology, 2019, Volume: 4, Issue:4

    Microscopic colitis is a chronic inflammatory disease of the colon that frequently causes chronic watery diarrhoea that might be accompanied by abdominal pain, nocturnal diarrhoea, urgency, and faecal incontinence. These symptoms lead to poor quality of life and increased health-care costs. Diagnosis relies on histological examination of multiple biopsy samples from the colonic mucosa, which often show no or only few abnormalities on endoscopy. Two major histological subtypes can be distinguished-collagenous colitis and lymphocytic colitis-but incomplete and variant forms with fewer characteristic features have been reported. Here we summarise the latest evidence on epidemiology, pathogenesis, and risk factors, and discuss established and novel therapeutic options for clinical remission. Finally, we propose an updated treatment algorithm. Further prospective studies are needed to clarify the natural history of microscopic colitis, supported by validated criteria for the assessment of disease activity.

    Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents; Budesonide; Colitis, Microscopic; Colon; Diarrhea; Endoscopy; Fecal Incontinence; Female; Health Care Costs; Humans; Immunologic Factors; Incidence; Intestinal Mucosa; Male; Middle Aged; Quality of Life; Remission Induction; Risk Factors

2019

Other Studies

1 other study(ies) available for pulmicort and Fecal-Incontinence

ArticleYear
Microscopic colitis: clinical characteristics, treatment and outcomes in an Irish population.
    International journal of colorectal disease, 2014, Volume: 29, Issue:7

    Many aspects of microscopic colitis remain poorly understood. Our aim was to report a single centre experience with this condition.. Two hundred and twenty-two patients (52 male, 170 female; median age 64 years; range 32-90) diagnosed between 1993 and 2010 were studied. Medical notes were reviewed, and data on age, gender, clinical features, history of autoimmune diseases, medication use, cigarette smoking, histology and outcome were collected.. There were 99 cases of lymphocytic and 123 of collagenous colitis. Diarrhoea was almost invariably present (98 %) while abdominal pain (24 %), weight loss (10 %), faecal incontinence (8 %) and blood PR (5 %) were also described. Twenty-eight percent had concomitant autoimmune diseases, most commonly coeliac disease. Patients were taking a variety of medications at diagnosis thought to be associated with microscopic colitis including NSAIDs (22 %), aspirin (19 %), statins (15 %), proton pump inhibitors (19 %) and SSRIs (10 %) at diagnosis. Prior to the widespread use of budesonide in our institution, 33 % of patients required two or more medications during therapy compared to 15 % following the introduction of budesonide (p = 0.001). Thirty-eight percent of patients achieved spontaneous remission with either no treatment or simple anti-diarrhoeals. Using a multivariate model, the only factor associated with spontaneous remission was male gender (RR 1.9; 95 % CI 1.0-3.6; p = 0.04). Two patients had refractory microscopic colitis; one required a colectomy while a more recent case has responded to anti-TNFα therapy.. Microscopic colitis is predominantly a benign and self-limiting disorder. The introduction of budesonide has revolutionised treatment of this lesser studied inflammatory bowel disease.

    Topics: Abdominal Pain; Aged; Anti-Inflammatory Agents; Budesonide; Colitis, Microscopic; Diarrhea; Fecal Incontinence; Female; Humans; Male; Middle Aged; Remission, Spontaneous; Retrospective Studies; Treatment Outcome; Weight Loss

2014